Almirall
FDA Approved Drugs
Almirall
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 15
- Latest Approval Date Dec 14, 2020
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Social Profiles
Company Snapshot
FDA Approved Drug Records ( 15 records )
Drug Name
ACZONE
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2005-07-07
Active Ingredient
DAPSONE
Application Number
21794
Product Number
1
Dosage Form
-
Strength
5%
Approval Date
2005-07-07
Regulatory Status
RX
Drug Name
ACZONE
Product Number
1
Dosage Form
-
Strength
7.5%
Approval Date
2016-02-24
Active Ingredient
DAPSONE
Application Number
207154
Product Number
1
Dosage Form
-
Strength
7.5%
Approval Date
2016-02-24
Regulatory Status
RX
Drug Name
ALTABAX
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2007-04-12
Active Ingredient
RETAPAMULIN
Application Number
22055
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2007-04-12
Regulatory Status
Discontinued
Drug Name
AVAGE
Product Number
3
Dosage Form
-
Strength
0.1%
Approval Date
2002-09-30
Active Ingredient
TAZAROTENE
Application Number
21184
Product Number
3
Dosage Form
-
Strength
0.1%
Approval Date
2002-09-30
Regulatory Status
RX
Drug Name
AZELEX
Product Number
1
Dosage Form
-
Strength
20%
Approval Date
1995-09-13
Active Ingredient
AZELAIC ACID
Application Number
20428
Product Number
1
Dosage Form
-
Strength
20%
Approval Date
1995-09-13
Regulatory Status
RX
Drug Name
CORDRAN
Product Number
1
Dosage Form
-
Strength
0.004MG/SQ CM
Approval Date
1982-01-01
Active Ingredient
FLURANDRENOLIDE
Application Number
16455
Product Number
1
Dosage Form
-
Strength
0.004MG/SQ CM
Approval Date
1982-01-01
Regulatory Status
RX
Drug Name
KLISYRI
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2020-12-14
Active Ingredient
TIRBANIBULIN
Application Number
213189
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2020-12-14
Regulatory Status
RX
Drug Name
SEYSARA
Product Number
1
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2018-10-01
Active Ingredient
SARECYCLINE HYDROCHLORIDE
Application Number
209521
Product Number
1
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2018-10-01
Regulatory Status
RX
Drug Name
SEYSARA
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2018-10-01
Active Ingredient
SARECYCLINE HYDROCHLORIDE
Application Number
209521
Product Number
2
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2018-10-01
Regulatory Status
RX
Drug Name
SEYSARA
Product Number
3
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2018-10-01
Active Ingredient
SARECYCLINE HYDROCHLORIDE
Application Number
209521
Product Number
3
Dosage Form
-
Strength
EQ 150MG BASE
Approval Date
2018-10-01
Regulatory Status
RX
Drug Name
SOLAGE
Product Number
1
Dosage Form
-
Strength
2%;0.01%
Approval Date
1999-12-10
Active Ingredient
MEQUINOL; TRETINOIN
Application Number
20922
Product Number
1
Dosage Form
-
Strength
2%;0.01%
Approval Date
1999-12-10
Regulatory Status
Discontinued
Drug Name
TAZORAC
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1997-06-13
Active Ingredient
TAZAROTENE
Application Number
20600
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
1997-06-13
Regulatory Status
RX
Drug Name
TAZORAC
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
1997-06-13
Active Ingredient
TAZAROTENE
Application Number
20600
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
1997-06-13
Regulatory Status
RX
Drug Name
TAZORAC
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2000-09-29
Active Ingredient
TAZAROTENE
Application Number
21184
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2000-09-29
Regulatory Status
RX
Drug Name
TAZORAC
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
2000-09-29
Active Ingredient
TAZAROTENE
Application Number
21184
Product Number
2
Dosage Form
-
Strength
0.1%
Approval Date
2000-09-29
Regulatory Status
RX
Drug Status Breakdown
15 total- RX
- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACZONE
Application Number
21794
Product Number
1
Active Ingredient
DAPSONE
Dosage Form
-
Strength
5%
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.